Literature DB >> 3065411

Salt intake and blood pressure in the general population: a controlled intervention trial in two towns.

J Staessen1, C J Bulpitt, R Fagard, J V Joossens, P Lijnen, A Amery.   

Abstract

A controlled trial was conducted in two Belgian towns to investigate the feasibility and effects of a reduction in salt consumption at the community level. The low-sodium intervention in one town was mainly directed at women and implemented through mass media techniques, while the control town was merely observed. Cross-sectional random sampling at baseline and 5 years later was employed, the participation rate being similar (67%) in the two towns. During the study a total of 2211 subjects were examined. In adult women (greater than or equal to 20 years) in the intervention town the 24-h urinary excretion of sodium (UVNa) decreased by 25 mmol/24 h (P less than 0.001) and this reduction differed (P = 0.01) from the concurrent trend in UVNa in the control town (+8 mmol/24 h). However, both systolic (SBP, -7.5 versus -7.9 mmHg) and diastolic (DBP, -2.3 versus -3.0 mmHg) pressures declined to a similar extent in the women from the two towns. In adult men in the intervention town, decreases were observed in UVNa (-12 mmol/24 h) and in SBP (-5.6 mmHg) and DBP (-2.4 mmHg), but these trends were not significantly different from the concurrent changes in the control town (-14 mmol/24 h, -4.9 and +0.2 mmHg, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3065411     DOI: 10.1097/00004872-198812000-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  17 in total

Review 1.  Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.

Authors:  A Chockalingam; D Abbott; M Bass; R Battista; R Cameron; J de Champlain; C E Evans; J Laidlaw; B L Lee; L Leiter
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

2.  Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study.

Authors:  J P Buchet; J Staessen; H Roels; R Lauwerys; R Fagard
Journal:  Occup Environ Med       Date:  1996-05       Impact factor: 4.402

3.  Sympathetic tone and relation between sodium intake and blood pressure in the general population.

Authors:  J Staessen; C J Bulpitt; L Thijs; R Fagard; J V Joossens; R Van Hoof; A Amery
Journal:  BMJ       Date:  1989-12-16

4.  Mother and child nutrition among the Chakhesang tribe in the state of Nagaland, North-East India.

Authors:  Thingnganing Longvah; Bewe Khutsoh; Indrapal Ishwarji Meshram; Sreerama Krishna; Venkaiah Kodali; Phrang Roy; Harriet V Kuhnlein
Journal:  Matern Child Nutr       Date:  2017-11       Impact factor: 3.092

5.  Cost and health consequences of reducing the population intake of salt.

Authors:  R M Selmer; I S Kristiansen; A Haglerod; S Graff-Iversen; H K Larsen; H E Meyer; K H Bonaa; D S Thelle
Journal:  J Epidemiol Community Health       Date:  2000-09       Impact factor: 3.710

Review 6.  Salt and sugar: their effects on blood pressure.

Authors:  Feng J He; Graham A MacGregor
Journal:  Pflugers Arch       Date:  2014-12-30       Impact factor: 3.657

7.  Salt reduction in a population for the prevention of hypertension.

Authors:  Hideaki Nakagawa; Katsuyuki Miura
Journal:  Environ Health Prev Med       Date:  2004-07       Impact factor: 3.674

8.  Effects of exposure to cadmium on calcium metabolism: a population study.

Authors:  J Staessen; A Amery; A Bernard; P Bruaux; J P Buchet; F Claeys; P De Plaen; G Ducoffre; R Fagard; R R Lauwerys
Journal:  Br J Ind Med       Date:  1991-10

Review 9.  Economics of hypertension control. World Hypertension League.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 10.  Sodium and potassium and the pathogenesis of hypertension.

Authors:  Katarzyna Stolarz-Skrzypek; Adam Bednarski; Danuta Czarnecka; Kalina Kawecka-Jaszcz; Jan A Staessen
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.